| Authors: |
Schmidt MA; Kaiser Permanente Center for Health Research, Portland, Oregon, USA. Electronic address: Mark.A.Schmidt@kpchr.org., Kuntz JL; Kaiser Permanente Center for Health Research, Portland, Oregon, USA., Shuster E; Kaiser Permanente Center for Health Research, Portland, Oregon, USA., Contreras R; Kaiser Permanente Southern California Department of Research & Evaluation, Pasadena, California, USA., Donald J; Kaiser Permanente Center for Health Research, Portland, Oregon, USA., Barreras JL; Kaiser Permanente Southern California Department of Research & Evaluation, Pasadena, California, USA., Angulo FJ; Vaccines and Antivirals Medical Affairs, Pfizer US Commercial Division, Collegeville, Pennsylvania, USA., Yu H; Health Economics and Outcomes Research, Vaccines, Pfizer, Inc., Collegeville, Pennsylvania, USA., Gonzalez E; Vaccines and Antivirals Medical Affairs, Pfizer US Commercial Division, Collegeville, Pennsylvania, USA., Zamparo JM; Vaccines and Antivirals Medical Affairs, Pfizer US Commercial Division, Collegeville, Pennsylvania, USA., Florea A; Kaiser Permanente Southern California Department of Research & Evaluation, Pasadena, California, USA., Tartof SY; Kaiser Permanente Southern California Department of Research & Evaluation, Pasadena, California, USA. |
